GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2018
    In:  Skeletal Radiology Vol. 47, No. 5 ( 2018-5), p. 605-605
    In: Skeletal Radiology, Springer Science and Business Media LLC, Vol. 47, No. 5 ( 2018-5), p. 605-605
    Type of Medium: Online Resource
    ISSN: 0364-2348 , 1432-2161
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2018
    detail.hit.zdb_id: 1461957-X
    detail.hit.zdb_id: 527592-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Informa UK Limited ; 2018
    In:  Baylor University Medical Center Proceedings Vol. 31, No. 2 ( 2018-04-03), p. 216-218
    In: Baylor University Medical Center Proceedings, Informa UK Limited, Vol. 31, No. 2 ( 2018-04-03), p. 216-218
    Type of Medium: Online Resource
    ISSN: 0899-8280 , 1525-3252
    Language: English
    Publisher: Informa UK Limited
    Publication Date: 2018
    detail.hit.zdb_id: 2703932-8
    detail.hit.zdb_id: 2205407-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Oxford University Press (OUP) ; 2013
    In:  Neuro-Oncology Vol. 15, No. suppl 3 ( 2013-11-01), p. iii165-iii172
    In: Neuro-Oncology, Oxford University Press (OUP), Vol. 15, No. suppl 3 ( 2013-11-01), p. iii165-iii172
    Type of Medium: Online Resource
    ISSN: 1522-8517 , 1523-5866
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2013
    detail.hit.zdb_id: 2028601-6
    detail.hit.zdb_id: 2094060-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    American Society of Hematology ; 2006
    In:  Blood Vol. 108, No. 11 ( 2006-11-16), p. 994-994
    In: Blood, American Society of Hematology, Vol. 108, No. 11 ( 2006-11-16), p. 994-994
    Abstract: Fanconi Anemia (FA) patients are at increased risk of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Impaired cell cycle regulation may have a role in this predisposition. Over-expression of p53, Ki-67 and survivin proteins has been reported in association with MDS. We analyzed bone marrow samples from 138 individuals: 31 FA, 17 acquired aplastic anemia (AA), 40 sporadic low-grade MDS (MDS-1: 35 refractory cytopenia with multilineage dysplasia [RCMD], 5 RCMD with ring sideroblasts [RCMD-RS] ), 11 high-grade MDS (MDS-2: refractory anemia with excess blasts [RAEB]), 12 AML, and 27 normal. To identify cell cycle regulation abnormalities that predict risk of MDS or AML in FA patients, we analyzed bone marrow morphology, cellularity, and immunohistochemical expression of cell cycle regulation proteins: p53 (cycle arrest and apoptosis), Ki-67 (cell proliferation), caspase-3 (apoptosis), and survivin (anti-apoptosis). Protein expression was classified as over-expressed if it was detected in a percentage of cells exceeding the highest values observed in normal marrow. Between group comparisons were made using the Fisher exact test. More FA marrows were hypocellular versus sporadic MDS-1, MDS-2 and AML (p & lt;0.0001 in all). p53 was over-expressed at similar rates in FA, MDS-1, MDS-2 and AML patients (12/25 vs. 22/35, 4/11 and 8/12; p = 0.3, 0.7 and 0.3, respectively); p53 was not over-expressed in AA (0/13, p = 0.003). Ki-67 was also over-expressed at similar rates in FA, MDS-2 and AML patients (9/18 vs. 3/11 and 7/12, p = 0.3 and 0.7), in whom over-expression was higher than in AA or MDS-1 (0/12 and 4/35). Survivin expression was more common in FA than in MDS-1, MDS-2, AML or AA (12/16 vs. 2/32, 0/10, 2/12 or 1/13; p & lt;0.01 for all comparisons). In contrast, the caspase-3 over-expression was higher in MDS-2 than in FA (4/11 vs. 0/18, p = 0.014). 7/31 FA patients had RCMD marrow changes; however, there was no correlation between morphologic features of myelodysplasia and the over-expression of cell cycle markers in these patients. p53 over-expression was frequent in FA, MDS-1, MDS-2, and AML; this distinguishes these disorders from AA. Previous studies found no p53 gene mutations in FA; thus, p53 over-expression observed here may represent upregulation of p53, or diminished p53 protein catabolism. Ki-67 over-expression may be a marker for higher grade MDS. The prevalence of over-expression of survivin was unique to FA, distinguishing it clearly from any of the acquired disorders (AA, MDS or AML), and may be a marker for any inherited bone marrow failure syndrome. Our cell cycle marker results suggest that patients in general in whom there is over-expression of Ki-67 and/or p53 may be at higher risk of evolution to MDS/AML; a longitudinal study is needed to address this prediction.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2006
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Elsevier BV ; 2008
    In:  Leukemia Research Vol. 32, No. 12 ( 2008-12), p. 1793-1799
    In: Leukemia Research, Elsevier BV, Vol. 32, No. 12 ( 2008-12), p. 1793-1799
    Type of Medium: Online Resource
    ISSN: 0145-2126
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2008
    detail.hit.zdb_id: 752396-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2014
    In:  Pediatric Nephrology Vol. 29, No. 1 ( 2014-1), p. 161-162
    In: Pediatric Nephrology, Springer Science and Business Media LLC, Vol. 29, No. 1 ( 2014-1), p. 161-162
    Type of Medium: Online Resource
    ISSN: 0931-041X , 1432-198X
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2014
    detail.hit.zdb_id: 1463004-7
    detail.hit.zdb_id: 631932-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2012
    In:  Pediatric Radiology Vol. 42, No. 1 ( 2012-1), p. 116-119
    In: Pediatric Radiology, Springer Science and Business Media LLC, Vol. 42, No. 1 ( 2012-1), p. 116-119
    Type of Medium: Online Resource
    ISSN: 0301-0449 , 1432-1998
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2012
    detail.hit.zdb_id: 1463007-2
    detail.hit.zdb_id: 124459-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    American Society of Clinical Oncology (ASCO) ; 2011
    In:  Journal of Clinical Oncology Vol. 29, No. 15_suppl ( 2011-05-20), p. e20002-e20002
    In: Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 29, No. 15_suppl ( 2011-05-20), p. e20002-e20002
    Type of Medium: Online Resource
    ISSN: 0732-183X , 1527-7755
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2011
    detail.hit.zdb_id: 2005181-5
    detail.hit.zdb_id: 604914-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2021
    In:  Journal of Pediatric Hematology/Oncology Vol. 43, No. 3 ( 2021-04), p. 116-116
    In: Journal of Pediatric Hematology/Oncology, Ovid Technologies (Wolters Kluwer Health), Vol. 43, No. 3 ( 2021-04), p. 116-116
    Type of Medium: Online Resource
    ISSN: 1077-4114
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2021
    detail.hit.zdb_id: 1231152-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    American Society of Hematology ; 2009
    In:  Blood Vol. 114, No. 22 ( 2009-11-20), p. 3207-3207
    In: Blood, American Society of Hematology, Vol. 114, No. 22 ( 2009-11-20), p. 3207-3207
    Abstract: Abstract 3207 Poster Board III-144 Introduction Fanconi anemia (FA) is a primarily autosomal recessive, genetically heterogeneous disorder of chromosomal instability associated with congenital anomalies, cancer susceptibility, and progressive bone marrow failure. Currently, hematopoietic stem-cell transplantation (SCT) is the only treatment that will restore normal hematopoeisis; transplant protocols and recommendations are modified routinely due to challenges with severe toxicities in pre-transplantation conditioning regimens as well as complications related to acute and chronic graft-versus-host disease. SCT may also increase the risk of subsequent solid tumors, particularly head and neck squamous cell carcinomas, and has a significant mortality rate among FA patients. Given these potential harms, the decision-making process about SCT in FA patients is complex. The purpose of this study was to survey FA patients and their families in the United States (USA) and Canada to gain a better understanding of the factors that influence their decisions about SCT. We explored how perceptions of the need and associated risks of SCT influence the choice to undergo SCT. Patients and Methods Individuals who were members of the FA family organizations in the USA and Canada were sent a self-report survey via a two-phase blinded mailing whereby non-responders from the first mailing were sent a second questionnaire. Parents and patients were queried separately. A single respondent was selected to represent each affected individual, according to the following selection hierarchy: mother as primary respondent, followed by father, adult patient, and spouse/significant other. Survey items about decision-making were adapted from The Beliefs about Medicines Questionnaire (Horne, Weinman, & Hankins, 1999) which assesses respondents' beliefs about the necessity, associated risks, and concerns regarding a medical intervention, in this case SCT. Each of the three predictor variables (necessity, risk and concern) was measured by core items rated on a 4-point Likert scale. The necessity subscale was measured by core items which evaluated the respondents' perception of the medical need for SCT. The risk subscale measured respondents' perceived likelihood that the patient would suffer from: physical or emotional side-effects of SCT, liver disease, infection, graft-versus-host-disease, infertility, post-SCT cancer, post-SCT leukemia, graft rejection, death, or hazards to future offspring. The concern subscale consisted of respondents' evaluation of the degree to which they were concerned about: physical or emotional side-effects of SCT, short or long-term side-effects, death, uncertainty about the procedure, effect of SCT on the patient's ability to do daily activities, financial difficulties, finding an adequate donor, and conflicts with religious or ethical beliefs. Logistic regression was used to examine the direct effect of each of the three predictor variables on the outcome variable, selection or refusal of SCT. Results Respondents for 223 individuals with FA (44% of those surveyed) were included in this analysis. The median age of patients at the time of diagnosis was 4.8 years (0-41 years); the median age at the time of transplant was 9.1 years (1.7-41.2 years). The majority of respondents were mothers (85%); fathers represented 10% of the final sample. A majority of patients included in the present analysis had SCT (83%), and a smaller majority were living at the time the survey was completed (64%). The subscale items exhibited good internal consistency reliability (αa 〉 0.80). In bivariate analyses, only perceived necessity and risk showed significant relationships with the outcome variable, SCT (p 〈 0.01). However, in multivariate logistic regression analyses including all three predictor variables, only perceived necessity of SCT was significantly associated with the decision to undergo SCT. Conclusions This is the first study to explore factors related to the utilization of SCT in FA. Our results demonstrated that the majority of subjects opted for SCT and that perceived necessity and risk of SCT were significantly related to the decision, while concern related to the SCT procedure was not. The perceived necessity of SCT was the most important factor for decision-making. These results suggest areas of emphasis for future research and counseling of FA patients and their family members. Disclosures No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2009
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...